Godavari Drugs Limited
BSE: GODAVARI.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Mukund Kakani
- Employees
- 111
- Headquarters
- Secunderabad, India
- IPO year
- 2024
- Market cap
- ₹980.1M
- Website
- http://www.godavaridrugs.com
Loading GODAVARI…
Loading profile data…Frequently asked questions about GODAVARI
What does Godavari Drugs Limited (GODAVARI.BO) do?
Godavari Drugs Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Ciprofloxacin Hydrochloride, Enrofloxacin, Centrizine Hydrochloride, Ethambutol Hydrochloride, A D Lactone, and Benzhyryl Piperazine. The company was founded on December 2, 1987 and is headquartered in Secunderabad, India.
Where does GODAVARI.BO trade?
Godavari Drugs Limited (GODAVARI.BO) trades on the Bombay Stock Exchange.
What sector is GODAVARI.BO in?
Godavari Drugs Limited (GODAVARI.BO) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Godavari Drugs Limited?
Mukund Kakani is the chief executive officer of Godavari Drugs Limited (GODAVARI.BO).
Where is Godavari Drugs Limited headquartered?
Godavari Drugs Limited is headquartered in India.
Does GODAVARI.BO pay a dividend?
Godavari Drugs Limited (GODAVARI.BO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GODAVARI.BO go public?
Godavari Drugs Limited (GODAVARI.BO) completed its initial public offering in 2024.